The Department of Veterans Affairs (VA) Veterans Health Administration awarded a Blanket Purchase Agreement (BPA) to Mdxhealth, Inc., a for-profit healthcare company, for the provision of specialized cancer diagnostic testing services. The BPA is under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract (FSS-621-II) and has a total potential value of $280,000 with an ultimate completion date of April 2, 2029. Specifically, the BPA covers DX Prostate Testing,...
This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA) to Mdxhealth, Inc., a for-profit healthcare company that provides molecular diagnostic services. The BPA, issued under Mdxhealth's existing General Services Administration (GSA) Federal Supply Schedule contract for Medical Laboratory Testing and Analysis Services, has a ceiling value of $320,000 and a period of performance...
This federal contract Indefinite Delivery Vehicle (IDV) is a Multiple Award Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Mdxhealth, Inc., a for-profit healthcare company. The contract, valued at up to $3,194,250.75, is for the provision of medical laboratory testing and analysis services, with a specific focus on advanced molecular diagnostic testing for cancer. Mdxhealth offers specialized genetic and epigenetic testing services such as...
This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17 to Mdxhealth, Inc., a for-profit healthcare company specializing in cancer diagnostics. The BPA, with a total ceiling value of $4,800,000, is for the provision of Oncotype DX prostate cancer testing services under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract. The period of performance...
This federal contract Indefinite Delivery Vehicle (IDV) is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) to Mdxhealth, Inc., a for-profit healthcare company based in Irvine, California. The contract, valued at up to $755,655.00, is for the provision of prostate cancer testing services under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The BPA has a period of performance from July 1, 2022 through...
This Blanket Purchase Agreement (BPA) is a single-award federal contract vehicle administered by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17 to procure cancer diagnostic testing services from MdxHealth, Inc., a for-profit healthcare company. The BPA calls for MdxHealth to provide its MDXHEALTH GPS molecular diagnostic services, which utilize genetic and epigenetic biomarkers to support personalized diagnosis and treatment for various cancers...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 1 to Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation. The single-award BPA, valued at $1,352,736, will provide the VA's VISN 1 facilities with an estimated 1,800 ExoDx Prostate (IntelliScore) tests over a five-year period. The ExoDx Prostate test is a non-invasive, urine-based liquid biopsy that analyzes exosomal RNA biomarkers to assess...
The Department of Veterans Affairs (VA) has awarded Biodesix, Inc., a for-profit medical laboratory and diagnostic testing company based in Boulder, Colorado, a $20.3 million multiple-award Federal Supply Schedule contract for medical laboratory testing and analysis services. This contract enables VA medical centers to issue task orders for Biodesix's specialized lung testing capabilities, including Nodify lung blood testing, STX lung cancer screening, and other diagnostic testing options....
The U.S. Department of Veterans Affairs (VA) has awarded a multiple-award Federal Supply Schedule (FSS) contract under the Medical Laboratory Testing and Analysis Services GSA Schedule (FSS-621-II) to Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation. This IDV contract, valued at $2,260,562, provides the VA with access to Exosome Diagnostics' non-invasive, urine-based liquid biopsy test, the ExoDx Prostate (IntelliScore), which analyzes exosomal RNA biomarkers to assess the risk...
This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 15 (VISN 15) of the U.S. Department of Veterans Affairs (VA) to Exact Sciences Corporation, specifically its Exact Sciences Laboratories, LLC division, for the provision of Oncotype DX cancer testing services. The BPA has a ceiling value of $900,925.40 and a period of performance from March 16, 2025 to March 15, 2026. Exact Sciences, which is the developer and manufacturer of the Cologuard colorectal...